Japanese startup H2L has introduced a breakthrough device that could change how we interact with robots. The Capsule Interface allows users to control humanoid robots through their muscle movements, ...

The BWEL trial showed significant weight loss in the WLI group, suggesting potential benefits in reducing cancer recurrence and mortality. The trial involved 3180 women with stage II/III HER2-negative ...

H2L, a Tokyo-based technology startup, has launched the Capsule Interface. This breakthrough device lets you control robots with your entire body, transmitting not just movement but also physical ...

Please provide your email address to receive an email when new articles are posted on . Remote intervention induced significant weight loss for women with breast cancer and obesity. Weight loss was ...